Immutep Limited Stock Performance
| PRRUF Stock | USD 0.26 0.00 0.00% |
On a scale of 0 to 100, Immutep holds a performance score of 10. The company retains a Market Volatility (i.e., Beta) of 0.31, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Immutep's returns are expected to increase less than the market. However, during the bear market, the loss of holding Immutep is expected to be smaller as well. Please check Immutep's information ratio and rate of daily change , to make a quick decision on whether Immutep's current trending patterns will revert.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Immutep Limited are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating basic indicators, Immutep reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 88.1 M | |
| Total Cashflows From Investing Activities | -22.9 K |
Immutep |
Immutep Relative Risk vs. Return Landscape
If you would invest 23.00 in Immutep Limited on February 6, 2024 and sell it today you would earn a total of 3.00 from holding Immutep Limited or generate 13.04% return on investment over 90 days. Immutep Limited is currently producing 0.2101% returns and takes up 1.611% volatility of returns over 90 trading days. Put another way, 14% of traded pink sheets are less volatile than Immutep, and 96% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Immutep Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immutep's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Immutep Limited, and traders can use it to determine the average amount a Immutep's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1304
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PRRUF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.61 actual daily | 14 86% of assets are more volatile |
Expected Return
| 0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Immutep is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immutep by adding it to a well-diversified portfolio.
Immutep Fundamentals Growth
Immutep Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Immutep, and Immutep fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Immutep Pink Sheet performance.
| Return On Equity | -0.38 | |||
| Return On Asset | -0.23 | |||
| Operating Margin | (7.18) % | |||
| Current Valuation | 142.99 M | |||
| Shares Outstanding | 879.09 M | |||
| Price To Earning | (2.50) X | |||
| Price To Book | 2.81 X | |||
| Price To Sales | 33.12 X | |||
| Revenue | 247.66 K | |||
| EBITDA | (43.69 M) | |||
| Cash And Equivalents | 80 M | |||
| Cash Per Share | 0.09 X | |||
| Total Debt | 2.11 M | |||
| Debt To Equity | 0.02 % | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | (30.23 M) | |||
| Earnings Per Share | (0.02) X | |||
| Total Asset | 148.52 M | |||
| Retained Earnings | (222 M) | |||
| Current Asset | 22 M | |||
| Current Liabilities | 1000 K | |||
About Immutep Performance
To evaluate Immutep Limited Pink Sheet as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Immutep generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Immutep Pink Sheet's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Immutep Limited market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Immutep's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products. Immutep Limited was incorporated in 1987 and is headquartered in Sydney, Australia. Immutep operates under Biotechnology classification in the United States and is traded on OTC Exchange.Things to note about Immutep Limited performance evaluation
Checking the ongoing alerts about Immutep for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Immutep Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Immutep Limited has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 247.66 K. Net Loss for the year was (32.21 M) with loss before overhead, payroll, taxes, and interest of (26.63 M). | |
| Immutep Limited has accumulated about 80 M in cash with (30.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09. |
- Analyzing Immutep's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Immutep's stock is overvalued or undervalued compared to its peers.
- Examining Immutep's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Immutep's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Immutep's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Immutep's pink sheet. These opinions can provide insight into Immutep's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Immutep Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Immutep Pink Sheet analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |